MBOT
Microbot Medical·NASDAQ
--
--(--)
--
--(--)
7.32 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: one strong‑buy rating (100%) from B. Riley. Fund‑flow metrics are strong, with a 7.72 score and ~48% inflow ratios across size segments, despite a negative trend label, indicating solid capital support.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionB. Riley Securities
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for MBOT?
- MBOT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.32/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
